The druggable genome and support for target identification and validation in drug development
Chris Finan, Anna Gaulton, Felix Kruger, Tom Lumbers, Tina Shah, Jorgen Engmann, Luana Galver, Ryan Kelly, Anneli Karlsson, Rita Santos, John Overington, Aroon Hingorani, Juan Pablo Casas
The paper connects GWAS loci to druggable genes, compounds, and clinical indications to identify drug development opportunities and design a genotyping array for druggable genome-wide association studies.
Science Translational Medicine · Mar 29, 2017Peer-reviewedGenetics